Compare OPNW & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OPNW | TLPH |
|---|---|---|
| Founded | 2023 | 2005 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.3M | 70.3M |
| IPO Year | 2013 | 2010 |
| Metric | OPNW | TLPH |
|---|---|---|
| Price | $1.74 | $1.08 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $3.13 |
| AVG Volume (30 Days) | 58.0K | ★ 119.7K |
| Earning Date | 11-16-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $16,398,000.00 | $2,151,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $15.79 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.79 | $0.69 |
| 52 Week High | $6.69 | $1.57 |
| Indicator | OPNW | TLPH |
|---|---|---|
| Relative Strength Index (RSI) | 16.62 | 42.64 |
| Support Level | N/A | $1.03 |
| Resistance Level | $6.69 | $1.14 |
| Average True Range (ATR) | 0.56 | 0.04 |
| MACD | -0.28 | 0.00 |
| Stochastic Oscillator | 0.20 | 33.33 |
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.